Literature DB >> 28792690

Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol.

Kengo Moriyama, Eiko Takahashi.   

Abstract

BACKGROUND: Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.
METHODS: This study included 778 Japanese subjects who were not taking medication for diabetes mellitus and dyslipidemia. All subjects underwent an annual health examination that included MDA-LDL analysis. Study subjects were divided into four groups according to mean values of LDL-C and MDA-LDL, and the metabolic profile was compared.
RESULTS: LDL cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were mainly associated with MDA-LDL. When subjects were stratified based on LDL-C levels, small dense LDL-C and MDA-LDL levels increased as LDL-C levels increased. Comparison of the characteristics of study subjects in the same LDL-C level group revealed that subjects with high MDA-LDL showed high metabolic risk in all LDL-C groups, particularly notable in the group with LDL-C levels < 120 mg/dL.
CONCLUSIONS: Our data indicated that high LDL-C and low HDL-C levels were independently associated with high MDA-LDL. To prevent high MDA-LDL, it is important to lower LDL-C level as well as to increase HDL-C even in subjects with low LDL-C level by lifestyle modification.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28792690     DOI: 10.7754/Clin.Lab.2017.170113

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  2 in total

1.  The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses.

Authors:  Kengo Moriyama
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

2.  Effects of Nutrition Education Program for the Japan Diet on Serum LDL-Cholesterol Concentration in Patients with Dyslipidemia: A Randomized Controlled Trial.

Authors:  Chizuko Maruyama; Yuri Shijo; Noriko Kameyama; Ariko Umezawa; Aisa Sato; Ai Nishitani; Makoto Ayaori; Katsunori Ikewaki; Masako Waki; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2021-01-17       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.